Sentinel Lymph Node Biopsy
"Sentinel Lymph Node Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm.
| Descriptor ID |
D021701
|
| MeSH Number(s) |
E01.370.225.500.384.100.580 E01.370.225.998.054.580 E01.370.388.100.580 E04.074.580 E04.446.819 E05.200.500.384.100.580 E05.200.998.054.580 E05.242.384.100.580
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sentinel Lymph Node Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Sentinel Lymph Node Biopsy".
This graph shows the total number of publications written about "Sentinel Lymph Node Biopsy" by people in this website by year, and whether "Sentinel Lymph Node Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 2 | 4 |
| 2001 | 17 | 5 | 22 |
| 2002 | 18 | 9 | 27 |
| 2003 | 12 | 6 | 18 |
| 2004 | 16 | 9 | 25 |
| 2005 | 22 | 6 | 28 |
| 2006 | 29 | 6 | 35 |
| 2007 | 18 | 10 | 28 |
| 2008 | 20 | 9 | 29 |
| 2009 | 12 | 14 | 26 |
| 2010 | 14 | 7 | 21 |
| 2011 | 20 | 13 | 33 |
| 2012 | 13 | 12 | 25 |
| 2013 | 10 | 9 | 19 |
| 2014 | 20 | 12 | 32 |
| 2015 | 18 | 7 | 25 |
| 2016 | 6 | 15 | 21 |
| 2017 | 12 | 11 | 23 |
| 2018 | 8 | 10 | 18 |
| 2019 | 7 | 14 | 21 |
| 2020 | 10 | 14 | 24 |
| 2021 | 4 | 16 | 20 |
| 2022 | 1 | 17 | 18 |
| 2023 | 1 | 18 | 19 |
| 2024 | 8 | 8 | 16 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sentinel Lymph Node Biopsy" by people in Profiles.
-
ASO Visual Abstract: Real-World Implications of the SOUND Trial. Ann Surg Oncol. 2025 Jan; 32(1):121-122.
-
Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025 Feb; 32(2):922-930.
-
Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2025 Jan; 32(1):84-91.
-
Real-World Implications of the SOUND Trial. Ann Surg Oncol. 2024 Dec; 31(13):8776-8785.
-
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study. Eur J Cancer. 2024 Nov; 211:114310.
-
The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Oct; 31(11):7339-7346.
-
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7249-7259.
-
Sentinel Node Biopsy in Oral Cancer-Indications, Analysis, and Outcomes. JAMA Otolaryngol Head Neck Surg. 2024 Jul 01; 150(7):634.
-
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. JAMA Oncol. 2024 Jun 01; 10(6):793-798.
-
Consensus on surgical technique for sentinel lymph node dissection in cervical cancer. Int J Gynecol Cancer. 2024 Apr 01; 34(4):504-509.